MM6A Stock Chart & Stats
€18.10
€0.00(0.00%)
At close: 4:00 PM EDT
€18.10
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€16.40 - €31.80
Previous CloseN/A
Volume0.00
Average Volume (3M)4.00
Market Cap
€2.99B
Enterprise Value€4.29K
Total Cash (Recent Filing)€193.77M
Total Debt (Recent Filing)€1.27B
Price to Earnings (P/E)17.3
Beta0.66
Next Earnings
Oct 29, 2026EPS Estimate
0.42Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.33
Shares Outstanding149,785,250
10 Day Avg. Volume0
30 Day Avg. Volume4
Financial Highlights & Ratios
PEG Ratio6.12
Price to Book (P/B)3.89
Price to Sales (P/S)0.91
P/FCF Ratio23.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€24.36Price Target Upside34.57% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
EPS Forecast (FY)1.62
Revenue Forecast (FY)€4.98B
Bulls Say, Bears Say
Bulls Say
Cash GenerationConsistently positive operating cash flow and very high FCF conversion (TTM ~93% of net income; Q2 OCF $184M) underpin durable ability to fund operations, invest in clinics/tech, pay down/ service debt and execute buybacks without relying on external financing.
Top-line Momentum & Portfolio BreadthStrong historical TTM revenue expansion and recent sequential growth reflect successful therapy adoption and volume recovery. Diverse portfolios (acute, IG neuro, rare/orphan) reduce single-product dependency and support sustainable volume-driven revenue growth over the coming quarters.
National Network & Site MixA broad ambulatory/home infusion footprint and recent clinic additions deepen payer relationships and referral capture, aligning with secular shifts toward lower-cost alternate-site care. Scale in sites and nursing suites supports cost efficiency and durable competitive positioning.
Bears Say
CID Portfolio HeadwindsChronic inflammatory (CID) product weakness is a material mix and volume drag expected to reduce revenue and gross profit (~600bps revenue, ~$55M GP). This structural portfolio gap can persist and compress margins and growth until coverage or product mix normalizes.
Margin CompressionNotable decline in net margin over recent periods signals mix and pricing pressure. Lower margins reduce internal funding for growth, increase sensitivity to reimbursement shifts, and make sustained EPS and cash targets harder to achieve absent margin recovery or cost gains.
Balance Sheet / Leverage ClarityManagement reports manageable but material leverage (net debt ~2.1x at Q2) and a TTM data inconsistency that obscures the latest debt picture. Moderate leverage limits strategic flexibility and raises risk if cash generation weakens or if execution falters.
MM6A FAQ
What was Option Care Health’s price range in the past 12 months?
Option Care Health lowest stock price was €16.40 and its highest was €31.80 in the past 12 months.
What is Option Care Health’s market cap?
Option Care Health’s market cap is €2.99B.
When is Option Care Health’s upcoming earnings report date?
Option Care Health’s upcoming earnings report date is Oct 29, 2026 which is in 87 days.
How were Option Care Health’s earnings last quarter?
Option Care Health released its earnings results on Jul 29, 2026. The company reported €0.391 earnings per share for the quarter, beating the consensus estimate of €0.37 by €0.021.
Is Option Care Health overvalued?
According to Wall Street analysts Option Care Health’s price is currently Undervalued.
Does Option Care Health pay dividends?
Option Care Health does not currently pay dividends.
What is Option Care Health’s EPS estimate?
Option Care Health’s EPS estimate is 0.42.
How many shares outstanding does Option Care Health have?
Option Care Health has 149,785,250 shares outstanding.
What happened to Option Care Health’s price movement after its last earnings report?
Option Care Health reported an EPS of €0.391 in its last earnings report, beating expectations of €0.37. Following the earnings report the stock price went up 3.209%.
Which hedge fund is a major shareholder of Option Care Health?
Currently, no hedge funds are holding shares in DE:MM6A
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Option Care Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€24.36 (34.57% Upside)
€24.36 (34.57% Upside)
Blogger Sentiment
Neutral
DE:MM6A Sentiment 50%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth €1.6M over
the Last 3 Months
the Last 3 Months
News Sentiment
Bullish
Bullish news 75%
Bearish news 25%
Bearish news 25%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-26.50%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-0.12%
Trailing 12-Months
Company Description
Option Care Health
Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion treatments, including therapies for various infections, management of heart failure, and comprehensive nutritional support (both intravenous and tube feeding) for individuals with acute or chronic conditions such as stroke, cancer, and digestive illnesses. They also provide immunoglobulin infusions for immune system deficiencies and treatments targeting chronic inflammatory disorders like Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Furthermore, Option Care Health assists in managing the progression of neurological conditions such as amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy. They also administer infusion therapies for bleeding disorders and provide crucial support for women experiencing high-risk pregnancies. Other specialized infusion services encompass pain relief, chemotherapy, and respiratory care. Complementing these medical offerings, the company provides professional nursing services. Option Care Health, Inc. maintains its primary corporate office in Bannockburn, Illinois.
MM6A Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a balance of meaningful operational and financial positives — including sequential revenue and EBITDA growth, strong cash generation ($184M in Q2), active share repurchases ($150M), clinic expansion, and progress in key portfolios (acute, IG neuro, rare/orphan) — while acknowledging persistent headwinds tied to the CID portfolio that are expected to depress 2026 revenue (~600 bps) and gross profit (~$55M). Management emphasized execution of commercial, technology and cost initiatives to drive sequential improvement through the back half of the year, but several initiatives and new therapy launches carry timing and execution risk.View all DE:MM6A earnings summariesMM6A Stock 12 Month Forecast
Average Price Target
€24.36
▲(34.57% Upside)
Technical Analysis
Addus Homecare
―
Chemed
―
National Healthcare
―
Surgery Partners
―
Aveanna Healthcare Holdings
―










